BAP1 and nonpapillary renal cell carcinoma: Thus, it is plausible to hypothesize that a similar mechanism is involved in our experimental settings, as evidenced by increased VPS34 binding to BECN1, as well as increased VPS34 activity in ccRCC cells expressing BAP1, compared to BAP1-deficient cell lines.